» Articles » PMID: 38541235

Sacral Neuromodulation: Device Improvement and Current Applications in Urology

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Mar 28
PMID 38541235
Authors
Affiliations
Soon will be listed here.
Abstract

Sacral neuromodulation (SNM) offers a therapeutic approach to urological patients suffering from idiopathic overactive bladder (OAB) syndrome, with or without incontinence and non-obstructive urinary retention (NOR), who are not responding to or are not compliant with conservative or medical therapies. The exact mechanism of action of SNM is not fully understood but modulation of the spinal cord reflexes and brain networks by peripheral afferents is regarded as the main pathway. Over the years, surgical techniques improved, leading to the development of the modern two-stage implantation technique. The quadripolar lead is positioned percutaneously under fluoroscopy guidance through the third sacral foramen following the trajectory of S3. The procedure can be performed under local or general anesthesia with the patient in prone position. Current applications of sacral neuromodulation in urology are increasing thanks to the recent improvements of the devices that make this a valuable option not only in conditions such as overactive bladder and non-obstructing urinary retention but also neurogenic lower urinary tract dysfunction.

Citing Articles

A Five-Year Retrospective Study on the Clinical Outcomes of Sacral Nerve Stimulation for Neuromodulation of the Lower Urinary Tract in a Tertiary Hospital.

Akpala A, Lezama T, Jinadu K, Belal M, King T Cureus. 2024; 16(11):e73626.

PMID: 39677101 PMC: 11645166. DOI: 10.7759/cureus.73626.

References
1.
Beer G, Gurule M, Komesu Y, Qualls C, Rogers R . Cycling Versus Continuous Mode In Neuromodulator Programming: A Crossover, Randomized, Controlled Trial. Urol Nurs. 2016; 36(3):123-32. PMC: 5248562. View

2.
van Kerrebroeck P, van Voskuilen A, Heesakkers J, Lycklama a Nijholt A, Siegel S, Jonas U . Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007; 178(5):2029-34. DOI: 10.1016/j.juro.2007.07.032. View

3.
Guzman-Negron J, Pizarro-Berdichevsky J, Gill B, Goldman H . Can Lumbosacral Magnetic Resonance Imaging be Performed Safely in Patients with a Sacral Neuromodulation Device? An In Vivo Prospective Study. J Urol. 2018; 200(5):1088-1092. DOI: 10.1016/j.juro.2018.05.095. View

4.
Liberman D, Ehlert M, Siegel S . Sacral Neuromodulation in Urological Practice. Urology. 2016; 99:14-22. DOI: 10.1016/j.urology.2016.06.004. View

5.
Drossaerts J, Rademakers K, Van Koeveringe G, Van Kerrebroeck P . The value of urodynamic tools to guide patient selection in sacral neuromodulation. World J Urol. 2015; 33(11):1889-95. PMC: 4617837. DOI: 10.1007/s00345-015-1479-6. View